List of Excipients in API lidocaine and tetracaine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lidocaine and tetracaine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Galen US Incorporated | SYNERA | lidocaine and tetracaine | 10885-002 | METHYLPARABEN | 1969-12-31 |
| Galen US Incorporated | SYNERA | lidocaine and tetracaine | 10885-002 | POLYVINYL ALCOHOL | 1969-12-31 |
| Galen US Incorporated | SYNERA | lidocaine and tetracaine | 10885-002 | PROPYLPARABEN | 1969-12-31 |
| Galen US Incorporated | SYNERA | lidocaine and tetracaine | 10885-002 | SORBITAN MONOPALMITATE | 1969-12-31 |
| Galen US Incorporated | SYNERA | lidocaine and tetracaine | 10885-002 | WATER | 1969-12-31 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for lidocaine and tetracaine
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
lidocaine and tetracaine drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
lidocaine and tetracaine drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Galen US Incorporated | lidocaine and tetracaine | 10885-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
lidocaine and tetracaine drug variants containing METHYLPARABEN
lidocaine and tetracaine drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
lidocaine and tetracaine drug variants containing PETROLATUM
lidocaine and tetracaine drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Galen US Incorporated | lidocaine and tetracaine | 10885-002 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
lidocaine and tetracaine drug variants containing POLYVINYL ALCOHOL
lidocaine and tetracaine drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
lidocaine and tetracaine drug variants containing PROPYLPARABEN
lidocaine and tetracaine drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOPALMITATE
lidocaine and tetracaine drug variants containing SORBITAN MONOPALMITATE
lidocaine and tetracaine drug variants not containing SORBITAN MONOPALMITATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
lidocaine and tetracaine drug variants containing WATER
lidocaine and tetracaine drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch